CHMP approve BristolMyers Squibb\'s Sprycel for paediatric patients with Ph ALL httpbit.ly2R2DARe cancer pharma oncology

CHMP approve Bristol-Myers Squibb's #Sprycel for paediatric patients with Ph+ ALL http://bit.ly/2R2DARe  #cancer #pharma #oncology

13:00 EST 17 Dec 2018 | Pharmafile

CHMP approve Bristol-Myers Squibb's #Sprycel for paediatric patients with Ph+ ALL http://bit.ly/2R2DARe  #cancer #pharma #oncology

More From BioPortfolio on "CHMP approve Bristol-Myers Squibb's #Sprycel for paediatric patients with Ph+ ALL http://bit.ly/2R2DARe  #cancer #pharma #oncology"